Doctor profile · Federal record
Dr. Rachel Farley-Loftus, M.D.
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Pediatric Dermatology Physician · Cedar Grove, NJ
- NPI 1285845941
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1425 Pompton Ave, Suite 1-1
Cedar Grove, NJ 070091043
(973) 785-8686
fax (973) 785-8680
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- March 13, 2013
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New Jersey #25MA09201200 · New York #245009
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285845941. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,430
Distinct HCPCS
10
Medicare allowed
$99,460
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 434 | 83 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 247 | 165 | $100 | |
17000 |
Destruction of precancer skin growth, 1 growth | 167 | 111 | $54 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 135 | 105 | $141 | |
11102 |
Biopsy of related skin growth, first growth | 101 | 81 | $109 | |
17110 |
Destruction of skin growth, 1-14 growths | 75 | 62 | $117 | |
11106 |
Incision biopsy, first skin growth | 62 | 58 | $180 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | 17 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 43 | 33 | $58 | |
11900 |
Injection into skin growth, 1-7 growths | 43 | 17 | $58 |
In context: peer comparison
Among 1 peers in Cedar Grove Dermatology Physician, average services per provider: 102. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$423
Transactions
27
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 5 | $77.11 | |
| Abbvie INC. | 4 | $66.25 | |
| Incyte Corporation | 3 | $45.16 | |
| Amgen INC. | 3 | $44.99 | |
| Lilly USA, LLC | 3 | $44.76 | |
| Galderma Laboratories, L.P. | 2 | $30.68 | |
| Genzyme Corporation | 1 | $18.62 | |
| Dermavant Sciences, INC. | 1 | $17.20 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $16.85 | |
| Celgene Corporation | 1 | $16.18 | |
| Arcutis Biotherapeutics, INC. | 1 | $15.70 | |
| Mayne Pharma Commercial LLC | 1 | $15.31 | |
| Sun Pharmaceutical Industries INC. | 1 | $14.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
169
Patients
75
Total drug cost
$80,208
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 34 | 30 | $368 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 26 | 20 | $633 |
| Clobetasol Propionate | Generic | 22 | 11 | $986 |
| Mupirocin | Generic | 16 | 14 | $196 |
| Tacrolimus | Generic | 15 | 0 | $5,033 |
| Metronidazole | Generic | 12 | 0 | $737 |
| Alclometasone Dipropionate | Generic | 11 | 0 | $426 |
| Fluorouracil | Generic | 11 | 0 | $1,093 |
| Mometasone Furoate | Generic | 11 | 0 | $325 |
| Otezla (Apremilast) | Brand | 11 | 0 | $70,411 |
Frequently asked questions
What is Dr. Rachel Farley-Loftus's medical specialty?
Dr. Rachel Farley-Loftus practices Dermatology Physician in Cedar Grove, NJ.
Where does Dr. Rachel Farley-Loftus practice?
Dr. Rachel Farley-Loftus practices at 1425 Pompton Ave, Cedar Grove, NJ 070091043. Office phone: 9737858686.
What is Dr. Rachel Farley-Loftus's NPI?
Dr. Rachel Farley-Loftus's National Provider Identifier (NPI) is 1285845941, issued by NPPES.
Does Dr. Rachel Farley-Loftus accept Medicare assignment?
Yes. Dr. Rachel Farley-Loftus accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Farley-Loftus commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.